Replies to post #399408 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I disagree. Hiring 40 expert employees like Advent has on staff to scale up and do all of the work to certify a GMP facility would easily cost many millions of dollars and require a much bigger balance sheet than is currently the case. There is no way they could be looked at in the same light with all of that on their balance sheet.

So I disagree completely as to your take and I see no other reason for them to have done this this time or the first time with Cognate. In the early days of these biotech products the FDA put very exciting opportunities effectively out of business by insisting that companies carry all of those costs on their balance sheets even before they did their first IND. It was ruinous. It would cost billions in capital costs before they even got to their trials. It was why everything required BP to be involved and it is why even to this day, BP expects to be involved or, in my opinion, behind the scenes they work to sabotage competitive efforts until they are brought in. Legalized protection money.

[Horseb4CarT]

Well for one benefit of the structure nwbo doesn’t have to hire their own production managers, employees, and Human Resources, and be directly burdened with all the related administrivia. It’s also a more nimble structure and easier to change if certain partnerships and/or mergers are offered and occur.

Taking on other clients than nwbo is better supported as well.

Ok, those are a few benefits not one.